Searchable abstracts of presentations at key conferences in endocrinology

ea0016p67 | Bone and calcium | ECE2008

Digital X-ray radiogrammetry in followed change of bone mineral density after the treatment in postmenopausal women

Galesanu Corina , Ciubotariu Ciprian , Galesanu Roxana Gabriela

Objectives: To evaluate the effect of alendronate, alfacalcidol, and combinat agent of alendronate and alfacalcidol, in BMD change assess by Digital X-ray Radiogrammetry in postmenopausal women.Materials and methods: Nine thousand and two hundred and sixty four healthy women with ages between 20 and 89 years referred to our densitometry service using DXR-BMD. Six thousand and six hundred and twelve from these were in postmenopause. Using WHO-criteria for...

ea0020p256 | Bone/Calcium | ECE2009

The change of bone mineral density in postmenopausal women treated by combined agent alendronate and alfacalcidol assessed by digital X-ray radiogrammetry

Galesanu Corina , Lisnic Natalia , Galesanu Mihail-Romeo , Ciubotariu Ciprian , Galesanu Roxana-Gabriela , Vasilica Rodica , Radu Dan , Ursuleanu Dan

Hypovitaminosis D is frequent in population over 65 years age, producing a secondary hyperparathyroidism, increase the bone remodeling, bone loss and osteoporotic fractures, loss of the muscle force.Daily dose of 0.5 μg alfacalcidol was effectively in improved muscle strength in elderly and reduced falls. The bisphosphonates have been shown to increase Bone Mineral Density (BMD) and reduce bone turnover in postmenopausal osteoporosis. The combined a...